Testing Sto M Tablet for Stomach Inflammation
Part of Digestive system clinical trials.
This study tests whether a medication called Sto M Tab helps people with acute or chronic gastritis (stomach lining inflammation). You must have had recent endoscopy confirming stomach erosions to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 19–75 years old
- Diagnosed with acute or chronic gastritis confirmed by upper endoscopy in the past 7 days, with at least one gastric erosion visible
- If able to become pregnant or father a child: agree to use effective contraception during the study and for 2 weeks after the last dose
- No active or healing peptic ulcers, reflux esophagitis, Barrett's esophagus, or other serious upper digestive lesions
- No history of stomach/esophageal surgery or acid-reducing surgery
- No inflammatory bowel disease (Crohn's, ulcerative colitis), blood clots, recent cancer, or severe liver, kidney, heart, or lung disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how diet relates to ongoing stomach inflammation (gastritis). It's for adults who've had stomach or digestive symptoms for at least a week. You might join if your symptoms are not caused by other conditions or medications.
This study watches patients with acute or chronic gastritis who are already being prescribed the stomach medicine Fexuclu (fexuprazan). It collects information to see how well the medicine works and if it causes any side effects in everyday use.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This trial tests an investigational tablet for people with long-term gallbladder inflammation (chronic cholecystitis) or bile duct movement problems (biliary dyskinesia). It aims to see if the tablet reduces stomach pain and other digestive symptoms.
This trial tests a herbal medicine called STW 5-II for people with functional dyspepsia (ongoing stomach pain or fullness without a clear cause). Researchers want to see if it helps heal the stomach lining and ease symptoms like bloating, pain, or feeling full quickly after meals.
This trial tests whether a combination of probiotics and ginger can improve symptoms and quality of life for people with functional dyspepsia (a condition causing ongoing stomach discomfort). Participants will take the supplement for several weeks and report how they feel.
Hear when a new Gastritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.